Skip to main content
Top

memo - Magazine of European Medical Oncology

Issue 1/2019

Content (20 Articles)

Lymphoma editorial

Editorial: critical issues in lymphoma management

David Fuchs, Clemens A. Schmitt

short review

Diffuse large B‑cell lymphoma

David Fuchs

Open Access Esophagus Resection review

Minimally invasive esophagectomy

Heinz Wykypiel, Thomas Schmid, Philipp Gehwolf

Open Access short review

Therapeutic endoscopic strategies in early esophageal cancer and dysplastic Barrett’s epithelium

Teresa Fritz, Rainer Schöfl, Friedrich Wewalka, Alexander Ziachehabi

Open Access short review

Radiochemotherapy in esophageal cancer

Elke Mayer, Christoph Reinhold Arnold, Ute Ganswindt, Robert Jäger

Surgical concepts in esophageal cancer

Paolo Nicola Camillo Girotti, Ingmar Königsrainer

Open Access short review

A case report of pseudo-progression after pembrolizumab in metastatic gastric cancer and a review of immunotherapy in gastroesophageal tumors

Hossein Taghizadeh, Katharina Lampichler, Andrea Beer, Matthias Preusser, Aysegul Ilhan-Mutlu

Open Access Breast Cancer short review

An update on immunotherapy in breast cancer

Rupert Bartsch, Elisabeth Bergen, Arik Galid

Open Access Prostate Cancer review

ESMO 2018—personal highlights

Isabel Heidegger, Wolfgang Hilbe, Andreas Pircher

Open Access Esophageal Cancer short review

Role of immune checkpoint inhibitors in gastrointestinal cancer treatment

Jakob Michael Riedl, Michael Stotz, Armin Gerger

Radiotherapy original report

Changes in patients’ quality of life during radiotherapy and 1 month after treatment

Osamu Tanaka, Yuka Kunishima, Takuya Taniguchi, Kousei Ono, Masayuki Matsuo

Open Access original report

Influencing factors on career choice and current occupation analysis of adult survivors of childhood cancer: a special focus on health-related occupations

Istvan-Szilard Szilagy, Eva Nagele, Christine Fürschuß, Andrea Mohapp, Karin Wiegele, Herwig Lackner, Christian Urban

case report

Kaposi sarcoma following autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia

Utku Iltar, Vedat Aslan, Mesut Gocer, Fatma Aykac, İlknur Nizam, Mehmet Çelik, Faruk Gulec, Turgay Ulaş, Erdal Kurtoğlu

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine